How miRview™ mets can help
CUP is a mystery
Tens of thousands of patients in the US alone are diagnosed with CUP each year. Many of these patients undergo a wide range of costly, time-consuming, and inefficient tests to try to find out where their cancer started
1. However, the primary origin of the cancer is never identified
2.
miRview™ mets can offer hope
Many of the tests currently used to identify the primary origin of CUP are inadequate.
1 miRview™ mets is a different kind of test. It uses cutting-edge technology as well as recently discovered and highly accurate biomarkers to identify the primary site.
The right diagnosis can make a difference
To determine your best course of treatment, your doctor needs to know where your cancer started. In most cases, miRview™ mets can provide answers. And that can help ensure that you start on the right treatment right away.
- Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer.
Cancer. 2004;100(9):1776-1785.
- Blaszyk H, Hartmann A, Bjornsson J. Cancer of unknown primary: clinicopathologic correlations.
APMIS. 2003;111(12):1089-1094.